Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI117907

VDIPEN, a metalloproteinase-generated neoepitope, is induced and immunolocalized in articular cartilage during inflammatory arthritis.

I I Singer, D W Kawka, E K Bayne, S A Donatelli, J R Weidner, H R Williams, J M Ayala, R A Mumford, M W Lark, and T T Glant

Division of Immunology and Inflammation, Merck Research Laboratories, Merck & Co., Inc., Rahway, New Jersey 07065, USA.

Find articles by Singer, I. in: PubMed | Google Scholar

Division of Immunology and Inflammation, Merck Research Laboratories, Merck & Co., Inc., Rahway, New Jersey 07065, USA.

Find articles by Kawka, D. in: PubMed | Google Scholar

Division of Immunology and Inflammation, Merck Research Laboratories, Merck & Co., Inc., Rahway, New Jersey 07065, USA.

Find articles by Bayne, E. in: PubMed | Google Scholar

Division of Immunology and Inflammation, Merck Research Laboratories, Merck & Co., Inc., Rahway, New Jersey 07065, USA.

Find articles by Donatelli, S. in: PubMed | Google Scholar

Division of Immunology and Inflammation, Merck Research Laboratories, Merck & Co., Inc., Rahway, New Jersey 07065, USA.

Find articles by Weidner, J. in: PubMed | Google Scholar

Division of Immunology and Inflammation, Merck Research Laboratories, Merck & Co., Inc., Rahway, New Jersey 07065, USA.

Find articles by Williams, H. in: PubMed | Google Scholar

Division of Immunology and Inflammation, Merck Research Laboratories, Merck & Co., Inc., Rahway, New Jersey 07065, USA.

Find articles by Ayala, J. in: PubMed | Google Scholar

Division of Immunology and Inflammation, Merck Research Laboratories, Merck & Co., Inc., Rahway, New Jersey 07065, USA.

Find articles by Mumford, R. in: PubMed | Google Scholar

Division of Immunology and Inflammation, Merck Research Laboratories, Merck & Co., Inc., Rahway, New Jersey 07065, USA.

Find articles by Lark, M. in: PubMed | Google Scholar

Division of Immunology and Inflammation, Merck Research Laboratories, Merck & Co., Inc., Rahway, New Jersey 07065, USA.

Find articles by Glant, T. in: PubMed | Google Scholar

Published May 1, 1995 - More info

Published in Volume 95, Issue 5 on May 1, 1995
J Clin Invest. 1995;95(5):2178–2186. https://doi.org/10.1172/JCI117907.
© 1995 The American Society for Clinical Investigation
Published May 1, 1995 - Version history
View PDF
Abstract

The destruction of articular cartilage in immune inflammatory arthritic disease involves the proteolytic degradation of its extracellular matrix. The role of activated matrix metalloproteinases (MMPs) in the chondrodestructive process was studied by identifying a selective cleavage product of aggrecan in murine arthritis models initiated by immunization with either type II collagen or proteoglycan. We conducted semiquantitative immunocytochemical studies of VDIPEN341 using a monospecific polyclonal antibody requiring the free COOH group of the COOH-terminal Asn for epitope detection. This antibody recognizes the aggrecan G1 domain fragment generated by MMP [i.e., stromelysin (SLN) or gelatinase A] cleavage of aggrecan between Asn341-Phe342 but does not recognize intact aggrecan. VDIPEN was undetectable in normal mouse cartilage but was observed in the articular cartilage (AC) of mice with collagen-induced arthritis 10 d after immunization, without histological damage and clinical symptoms. This aggrecan neoepitope was colocalized with high levels of glycosaminoglycans (GAGs) in pericellular matrices of AC chondrocytes but was not seen at the articular surface at this early time. Digestion of normal (VDIPEN negative) mouse paw cryosections with SLN also produced heavy pericellular VDIPEN labeling. Computer-based image analysis showed that the amount of VDIPEN expression increased dramatically by 20 d (70% of the SLN maximum) and was correlated with GAG depletion. Both infiltration of inflammatory cells into the synovial cavity and early AC erosion were also very prominent at this time. Analysis of adjacent sections showed that both induction of VDIPEN and GAG depletion were strikingly codistributed within sites of articular cartilage damage. Similar results occurred in proteoglycan-induced arthritis, a more progressive and chronic model of inflammatory arthritis. These studies demonstrate for the first time the MMP-dependent catabolism of aggrecan at sites of chondrodestruction during inflammatory arthritis.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 2178
page 2178
icon of scanned page 2179
page 2179
icon of scanned page 2180
page 2180
icon of scanned page 2181
page 2181
icon of scanned page 2182
page 2182
icon of scanned page 2183
page 2183
icon of scanned page 2184
page 2184
icon of scanned page 2185
page 2185
icon of scanned page 2186
page 2186
Version history
  • Version 1 (May 1, 1995): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts